HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 1 to 15 of 15
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
articleSho, Takuya; Suda, Goki; Ogawa, Koji; Kimura, Megumi; Shimazaki, Tomoe; Maehara, Osamu; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Morikawa, Kenichi; Furuya, Ken; Baba, Masaru; Yamamoto, Yoshiya; Kobayashi, Tomoe; Meguro, Takashi; Saga, Akiyoshi; Miyagishima, Takuto; Yokoo, Hideki; Kamiyama, Toshiya; Taketomi, Akinobu; Sakamoto, NaoyaEarly response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting-JGH open-Feb-2020
articleOgawa, Koji; Kobayashi, Takashi; Furukawa, Jun-ichi; Hanamatsu, Hisatoshi; Nakamura, Akihisa; Suzuki, Kazuharu; Kawagishi, Naoki; Ohara, Masatsugu; Umemura, Machiko; Nakai, Masato; Sho, Takuya; Suda, Goki; Morikawa, Kenichi; Baba, Masaru; Furuya, Ken; Terashita, Katsumi; Kobayashi, Tomoe; Onodera, Manabu; Horimoto, Takahiro; Shinada, Keisuke; Tsunematsu, Seiji; Tsunematsu, Izumi; Meguro, Takashi; Mitsuhashi, Tomoko; Hato, Megumi; Higashino, Kenichi; Shinohara, Yasuro; Sakamoto, NaoyaTri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis : a novel glycobiomarker for non-alcoholic steatohepatitis-Scientific reports-15-Jan-2020
article (author version)Sugiura, Ryo; Kuwatani, Masaki; Nishida, Mutsumi; Hirata, Koji; Sano, Itsuki; Kato, Shin; Kawakubo, Kazumichi; Nakai, Masato; Sho, Takuya; Suda, Goki; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, NaoyaCORRELATION BETWEEN LIVER ELASTICITY BY ULTRASOUND ELASTOGRAPHY AND LIVER FUNCTIONAL RESERVE-Ultrasound in medicine and biology-Oct-2019
article (author version)Kobayashi, Takashi; Ogawa, Koji; Furukawa, Jun-ichi; Hanamatsu, Hisatoshi; Hato, Megumi; Yoshinaga, Tomoyo; Morikawa, Kenichi; Suda, Goki; Sho, Takuya; Nakai, Masato; Higashino, Kenichi; Numata, Yoshito; Shinohara, Yasuro; Sakamoto, NaoyaQuantifying Protein-Specific N-Glycome Profiles by Focused Protein and Immunoprecipitation Glycomics-Journal of proteome research-Aug-2019
articleSuda, Goki; Nakai, Masato; Sho, Takuya; Kimura, Megumi; Shimazaki, Tomoe; Maehara, Osamu; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Baba, Masaru; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, NaoyaThe Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment-Internal medicine-1-Apr-2019
articleOhara, Masatsugu; Ogawa, Koji; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Shimazaki, Tomoe; Suzuki, Kazuharu; Nakamura, Akihisa; Umemura, Machiko; Izumi, Takaaki; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ohnishi, Shunsuke; Sakamoto, NaoyaL-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis-Hepatology communications-Aug-2018
article (author version)Nakai, Masato; Ogawa, Koji; Takeda, Rei; Ohara, Masatsugu; Kawagishi, Naoki; Izumi, Takaaki; Umemura, Machiko; Ito, Jun; Sho, Takuya; Suda, Goki; Morikawa, Kenichi; Sakamoto, NaoyaIncreased serum C-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosisPredictive factors of tolvaptan efficacy for LCHepatology Research-Feb-2018
articleKawagishi, Naoki; Suda, Goki; Nakamura, Akinobu; Kimura, Megumi; Maehara, Osamu; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Izumi, Takaaki; Umemura, Machiko; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Kudo, Yusuke; Nishida, Mutsumi; Miyoshi, Hideaki; Sakamoto, NaoyaLiver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis-PLOS ONE-2018
articleSho, Takuya; Nakanishi, Mitsuru; Morikawa, Kenichi; Ohara, Masatsugu; Kawagishi, Naoki; Izumi, Takaaki; Umemura, Machiko; Ito, Jun; Nakai, Masato; Suda, Goki; Ogawa, Koji; Chuma, Makoto; Meguro, Takashi; Nakamura, Michio; Nagasaka, Atsushi; Horimoto, Hiromasa; Yamamoto, Yoshiya; Sakamoto, NaoyaA Phase I Study of Combination Therapy with Sorafenib and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma-Drugs in R&D-Sep-2017
article (author version)Suda, Goki; Kudo, Mineo; Nagasaka, Atsushi; Furuya, Ken; Yamamoto, Yoshiya; Kobayashi, Tomoe; Shinada, Keisuke; Tateyama, Miki; Konno, Jun; Tsukuda, Yoko; Yamasaki, Kazushi; Kimura, Megumi; Umemura, Machiko; Izumi, Takaaki; Tsunematsu, Seiji; Sato, Fumiyuki; Terashita, Katsumi; Nakai, Masato; Horimoto, Hiromasa; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, NaoyaEfficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C-Journal of gastroenterology-Jul-2016
article (author version)Suda, Goki; Yamamoto, Yoshiya; Nagasaka, Astushi; Furuya, Ken; Kudo, Mineo; Chuganji, Yoshimichi; Tsukuda, Yoko; Tsunematsu, Seiji; Sato, Fumiyuki; Terasita, Katsumi; Nakai, Masato; Horimoto, Hiromasa; Sho, Takuya; Natsuizaka, Mitsuteru; Ogawa, Kouji; Ohnishi, Shunsuke; Chuma, Makoto; Fujita, Yasuyuki; Abe, Riichiro; Taniguchi, Miki; Nakagawa, Mina; Asahina, Yasuhiro; Sakamoto, NaoyaSerum granulysin levels as a predictor of serious telaprevir-induced dermatological reactions-Hepatology research-Aug-2015
article (author version)Sho, Takuya; Tsukiyama, Tadasuke; Sato, Tomonobu; Kondo, Takeshi; Cheng, Jun; Saku, Takashi; Asaka, Masahiro; Hatakeyama, ShigetsuguTRIM29 negatively regulates p53 via inhibition of Tip60-Biochimica et Biophysica Acta (BBA) : Molecular Cell Research-Jun-2011
article (author version)Shinada, Keisuke; Tsukiyama, Tadasuke; Sho, Takuya; Okumura, Fumihiko; Asaka, Masahiro; Hatakeyama, ShigetsuguRNF43 interacts with NEDL1 and regulates p53-mediated transcription-Biochemical and Biophysical Research Communications-7-Jan-2011
article (author version)Hige, Shuhei; Yamamoto, Yoichi; Yoshida, Shigeru; Kobayashi, Tomoe; Horimoto, Hiromasa; Yamamoto, Keiko; Sho, Takuya; Natsuizaka, Mitsuteru; Nakanishi, Mitsuru; Chuma, Makoto; Asaka, MasahiroSensitive Assay for Quantification of Hepatitis B Virus Mutants by Use of a Minor Groove Binder Probe and Peptide Nucleic Acids-Journal of Clinical Microbiology-Dec-2010
article (author version)Chuma, Makoto; Hige, Shuhei; Kamiyama, Toshiya; Meguro, Takashi; Nagasaka, Atsushi; Nakanishi, Kazuaki; Yamamoto, Yoshiya; Nakanishi, Mitsuru; Kohara, Toshihisa; Sho, Takuya; Yamamoto, Keiko; Horimoto, Hiromasa; Kobayashi, Tomoe; Yokoo, Hideki; Matsushita, Michiaki; Todo, Satoru; Asaka, MasahiroThe influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma-Journal of Gastroenterology-Sep-2009
Showing results 1 to 15 of 15

 

Hokkaido University